HeraMED Limited (ASX:HMD)
Australia · Delayed Price · Currency is AUD 0.0340
0.00 (0.00%)
Aug 6, 2026, 11:53 AM AEST
HeraMED Market Cap
HeraMED has a market cap or net worth of 39.35 million as of August 7, 2026. Its market cap has increased by 164.39% in one year.
Market Cap
39.35M
Enterprise Value
37.98M
Revenue
431.61K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.03
ChartMarket Cap Chart
Since December 12, 2018, HeraMED's market cap has increased from 15.76M to 39.35M, an increase of 149.79%. That is a compound annual growth rate of 12.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 39.35M | 2.15% |
| Dec 31, 2025 | 38.53M | 120.00% |
| Dec 31, 2024 | 17.51M | 127.12% |
| Dec 29, 2023 | 7.71M | -74.58% |
| Dec 30, 2022 | 30.33M | -32.86% |
| Dec 31, 2021 | 45.18M | 173.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cyclopharm | 68.71M |
| Epiminder | 68.15M |
| Compumedics | 46.94M |
| Cleo Diagnostics | 45.93M |
| Nova Eye Medical | 41.30M |
| OncoSil Medical | 38.92M |
| CleanSpace Holdings | 32.35M |
| Control Bionics | 31.17M |